Postdoctoral position for up to 3 years in PARIS, FRANCE
at the Research Center of Inflammation (CRI) (INSERM, Université de Paris Cité)
Targeting the Adapted colonic Microbiota for a better recovery after Intestinal Resection (AdMIR)

© Lorem ipsum dolor sit amet, consectetuer adipiscing

Employer:

A Post-doctoral position is available starting in January 2023 in the PIMs team at the Research Center of Inflammation in PARIS (https://cri1149.fr/en/equipes/le-gall-bado) Our team focus on the contribution of the gastrointestinal tract to nutritional pathologies from obesity to undernutrition, in particular short bowel syndrome (SBS). Our team gathers physiologists of the gastro-intestinal tract, basic scientists and clinicians (digestive surgeons, gastroenterologists and nutritionists) to develop basic and translational research to study gastrointestinal adaptations in response to surgical remodeling. We set up unique rat models of bariatric surgeries and short bowel syndrome and combine experimental research in these preclinical models with clinical studies.

Scientific goal:

Short bowel syndrome (SBS), a rare disease, is the main cause of intestinal failure. SBS results from an extensive intestinal resection leading to malabsorption and wasting conditions. Physiological adaptations improving nutrient absorption capacities appear spontaneously over time in SBS patients. Oral nutrition and presence of the colon are two major positive drivers for these adaptations. Microbiota dysbiosis (“lactobiota”), modifications of intestinal epithelium (colonic and jejunal hyperplasia, increased levels of distally produced gut hormones such as GLP-2…) and hyperphagia, altogether contribute to energy and hydroelectrolytic recovery although underlying mechanisms are unknown.
The SBS lactobiota is thought to be a reservoir of multiple and complex signals driving hyperplasia and hormone (GLP-2…) secretions in the colon that could contribute to post-resection adaptive mechanisms. AdMIR project questions how microbiota improves intestinal malabsorption over time in SBS subjects. The ultimate goals are to accelerate and drive better jejunal absorption by promoting and targeting colonic adaptation. Two main objectives are proposed:
– To determine the role and specificity of the SBS microbiota, identify specific contribution of microbiota strains or metabolites involved in the mechanism by which this microbiota improves intestinal adaptation and recovery during SBS.
– To assess the impact of GLP-2 signalling in relaying, totally or partially, the microbiota effects on adaptation and recovery during SBS.

Candidate profile/Required skills:

We are looking for a rigorous candidate with creative and collaborative spirit. She/He must be autonomous and able to adapt quickly to different lab/team settings. The project will require a wide variety of techniques in different fields including intestinal homeostasis, nutrition, microbiology and cell culture (organoids). The candidate should have a recent PhD /1st postdoc experience, have strong knowledge in gut physiology and its interaction with microbiota with expertise in intestinal organoid culture. She/He should have the required authorization to perform animal experiments and good experience with rats and in vivo approaches. Skills in bioinformatics would be a plus.

Research environment:

The position is funded by an ANR grant (AdMIR project). The postdoctal scientist will work with the PI Johanne Le Beyec-Le Bihan in the team PIMS head by Maude le Gall and André Bado. Within the AdMIR group, the post-doctoral fellow will also collaborate with a graduate student and an assistant engineer. The successful candidate will be required to work with the 4 partners of the project: the Probihote Team at MICALIS INRAE (Dr. Muriel Thomas), the laboratory of Functionnal Coprology at Pitie-Salpetrière Hospital APHP (Pr. Nathalie Kapel), the laboratory of drug metabolism at CEA (Dr François Fenaille) and the Gastroenterology and Nutrition Support department at Beaujon Hospital APHP (Pr. Francisca Joly).
Application process: Highly motivated candidates can send a cover letter with motivations, a short summary of achievements and mastered techniques, a curriculum vitae with publication and communication list, and the names of (at least) two referees.
Applications should be sent by email to johanne.le-beyec@inserm.fr before March15th 2023.
Please indicate “Post-doc AdMIR Application” in the title of the email.

Read more

A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer

A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer

Pancreatic ductal adenocarcinoma is currently the fourth leading cause of cancer death worldwide. It is projected to become the second leading cause of cancer death by 2030. Unfortunately, PDAC is often diagnosed at an advanced stage, resulting in a 5-year survival rate of less than 10%. Since the most common precancerous lesions of PDAC are currently not clinically detectable, understanding the mechanisms that lead to their formation and progression is crucial to enabling early diagnosis and more effective therapeutic intervention.

Journée Thématique SFD

Journée Thématique SFD

la Journée Thématique de la SFD aura lieu cette année le 15 décembre 2023 à l’Institut Pasteur de Paris, et sera consacrée au sujet «Diabète, îlots et Insulino-Sécrétion».